| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.24 | 0.08 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |